| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/04/2002 | CN1367695A Phthalazine derivatives for treating inflammatory diseases |
| 09/04/2002 | CN1367693A Pharmaceutical compositions containing poly(ADP-ribose) glycohydrolase inhibitors and method of using the same |
| 09/04/2002 | CN1367029A Therapeutic patch |
| 09/04/2002 | CN1367017A Application of transitional scorpion toxin BmK abT |
| 09/04/2002 | CN1367015A Nano supplemented ganoderma fungus preparation medicine and its preparation method |
| 09/04/2002 | CN1366990A Optimum matching ratio of salvia root and notoginseng for curing angiocardiopathy |
| 09/04/2002 | CN1366986A Cinnamon twig decoction extract for preventing and curing hypertension |
| 09/04/2002 | CN1366985A Blood pressure reducing plaster |
| 09/04/2002 | CN1366975A Nano Guijia Yangyin preparation medicine and preparation method |
| 09/04/2002 | CN1366957A Nano Bawei Shenqi preparation medicine and preparation method |
| 09/04/2002 | CN1366956A Nano An'gong blood pressure-reducing preparation medicine and preparation method |
| 09/04/2002 | CN1366939A Nano Danshen heart-benefiting preparation medicine and preparation method |
| 09/04/2002 | CN1366938A Nano Huishengzaizao preparation medicine and preparation method |
| 09/04/2002 | CN1366933A Nano Qiyeshen'an preparation medicine and preparation method |
| 09/04/2002 | CN1366929A Nano Huangyangning preparation medicine and preparation method |
| 09/04/2002 | CN1366915A Nano brain-benefiting blood pressure-reducing preparation medicine and preparation method |
| 09/04/2002 | CN1366913A Nano Xinkening preparation and preparation method |
| 09/04/2002 | CN1366912A Nano Naodesheng preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366902A Nano heart-benefiting preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366900A Nano lingbao huxin preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366897A Nano hemp seed preparation and preparation method thereof |
| 09/04/2002 | CN1090190C Heterocycle-condensed morphinoid derivatives and its preparing method and use |
| 09/04/2002 | CN1090189C Pyrazolopyrimidines type compound |
| 09/04/2002 | CN1090184C Heterocyclic compounds and preparing method thereof |
| 09/04/2002 | CN1090029C Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
| 09/04/2002 | CN1090028C Medicine for treatment of restenosis and arteriosclerosis |
| 09/04/2002 | CN1090027C Immunity-strengthening and infection-preventing medicine |
| 09/04/2002 | CN1090021C Preparation method and use of sulfated oligosaccharides |
| 09/04/2002 | CN1090020C 4,4-(disubstituted) cyclohexan-1-ols and related compounds |
| 09/03/2002 | US6444829 (2s,4r)-4-mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carboxylic acid n'-isobutyl-n'-(4-methyl-benzenesulfonyl)-hydrazide, for example; inhibitors of metalloproteases, e.g. zinc proteases; vasodilators |
| 09/03/2002 | US6444821 Humidity-controlling the crystals of n-(2-(4-(5h-dibenzo(a,d)cyclohepten-5-ylidene)-piperidino)ethyl)-1-formyl-4 -piperidinecarboxamide hydrochloride anhydride |
| 09/03/2002 | US6444810 Acylmercaptoalkanoylamino lactam esters or acids are converted to the corresponding mercaptoalkanoylamino lactam ester or acid under basic conditions using an agent that minimizes amount of disulfides |
| 09/03/2002 | US6444709 Skin disorders; antiinflammatory agents; antiarthritic agents; cardiovascular disorders |
| 09/03/2002 | US6444702 Central nervous system disorders |
| 09/03/2002 | US6444701 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 09/03/2002 | US6444696 1-aryl or heteroaryl substituted 5-amino-4 carbonylpyrazole derivatives; antiinflammatory agents |
| 09/03/2002 | US6444694 Styryl benzimidazole derivatives |
| 09/03/2002 | US6444691 1,3-disubstituted ureas as ACAT inhibitors, and method of preparing thereof |
| 09/03/2002 | US6444688 Compounds and compositions with nitrogen-containing non-basic side chains |
| 09/03/2002 | US6444679 Neurological and gastrointestinal disorders; delta opioid ligands or opioid receptors |
| 09/03/2002 | US6444677 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 09/03/2002 | US6444663 Treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, and for the prevention of ischemic injury. |
| 09/03/2002 | US6444642 Administering to mammal effective amount of neuregulin polypeptide with p185.sup.erbb2 protein binding activity to stimulate myogenesis of muscle cells |
| 09/03/2002 | US6444639 Human chorionic gonadotrophin (hcg) used to treat or prevent tumors, multiple sclerosis, inflammation or angiogenesis-dependent diseases |
| 09/03/2002 | US6444434 Compounds inhibiting the activation of fx to fxa by tf/fviia. the compounds are anticoagulants. the invention also relates to a method of identifying a drug candidate. |
| 09/03/2002 | US6444431 Angiostatin receptor |
| 09/03/2002 | CA2237189C 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 09/03/2002 | CA2234051C Novel isoquinoline derivatives |
| 09/03/2002 | CA2232985C Methods for treating cancers and restenosis with p21 |
| 09/03/2002 | CA2178085C Glutaramide derivatives |
| 09/03/2002 | CA2140626C Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 09/01/2002 | CA2373578A1 .beta.3, agonists and uses thereof |
| 08/29/2002 | WO2002066978A2 Detection of compounds that modulate inflammatory responses |
| 08/29/2002 | WO2002066681A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 08/29/2002 | WO2002066647A2 Type 2 ctokine receptor and nucleic acids encoding same |
| 08/29/2002 | WO2002066646A2 Neurotransmission-associated proteins |
| 08/29/2002 | WO2002066635A1 Transgenic animal having drug metabolism enzyme gene and utilization thereof |
| 08/29/2002 | WO2002066617A1 Method for detecting a risk of hypertension and uses thereof |
| 08/29/2002 | WO2002066516A2 Antibodies that bind both bcma and taci |
| 08/29/2002 | WO2002066512A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 08/29/2002 | WO2002066505A2 Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof |
| 08/29/2002 | WO2002066498A2 Peptide inhibiting platelet derived growth factor (pdgf-bb) and fibroblast growth factor (bfgf) activity |
| 08/29/2002 | WO2002066494A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
| 08/29/2002 | WO2002066481A1 Pyrimidine derivatives for inhibition of cell-proliferation |
| 08/29/2002 | WO2002066470A1 Substituted alkylamine derivatives and methods of use |
| 08/29/2002 | WO2002066463A1 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors |
| 08/29/2002 | WO2002066461A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/29/2002 | WO2002066460A1 Chemical compounds |
| 08/29/2002 | WO2002066459A1 Indole derivatives and their use as gnrh antagonists |
| 08/29/2002 | WO2002066458A2 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry |
| 08/29/2002 | WO2002066450A2 Anthrone derivatives and their use as ink inhibitors |
| 08/29/2002 | WO2002066447A1 4h-1,2,4-triazole-3(2h)-thione deratives as sphingomyelinase inhibitors |
| 08/29/2002 | WO2002066445A1 Quinazoline derivatives |
| 08/29/2002 | WO2002066443A2 2-thioxo-1,2,3,4-tetrahydropyrimidine derivatives |
| 08/29/2002 | WO2002066431A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 08/29/2002 | WO2002066430A1 Tryptase inhibitors |
| 08/29/2002 | WO2002066422A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 08/29/2002 | WO2002066421A1 Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects |
| 08/29/2002 | WO2002066420A2 Tryptase inhibitors |
| 08/29/2002 | WO2002066073A1 Method of examining effect of angionegesis inhibitor mediated by the inhibition of integrin expression |
| 08/29/2002 | WO2002066069A1 Remedies for inflammatory/tumor diseases |
| 08/29/2002 | WO2002066061A1 Active oxygen generator containing photosensitizer for ultrasonic therapy |
| 08/29/2002 | WO2002066050A1 Casoase 3 inhibitors |
| 08/29/2002 | WO2002066035A2 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/29/2002 | WO2002066034A1 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors |
| 08/29/2002 | WO2002066028A2 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids |
| 08/29/2002 | WO2002065985A2 Methods of treating diabetes mellitus |
| 08/29/2002 | WO2002065978A2 Functional agent for decomposing nicotine and method of preparing the same |
| 08/29/2002 | WO2002065977A2 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof |
| 08/29/2002 | WO2002065859A1 Emulsions and aqueous dispersions of phytosterols |
| 08/29/2002 | WO2002065834A2 Novel formulations of carvedilol |
| 08/29/2002 | WO2002042273A3 Acid derivatives useful as serine protease inhibitors |
| 08/29/2002 | WO2002028867A3 Ethers of 7-desmethylrapamycin for use in immunosuppression |
| 08/29/2002 | WO2002028858A3 Hexahydropyrazino `1'2' : 1, 6!- pyrido `3, 4-b! indole-1, 4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
| 08/29/2002 | WO2002022795A3 Isolated human kinase proteins, nucleic acid molecules and uses thereof |
| 08/29/2002 | WO2002022621A3 INTERPHENYLENE 7-OXABICYCLIC[2.2.1]HEPTANE OXAZOLES AS PROSTAGLANDIN F2a ANTAGONISTS |
| 08/29/2002 | WO2002022620A3 Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin f2$g(a) antagonists |
| 08/29/2002 | WO2002020723A3 Compositions and methods for targeting peptides in humans in vivo |
| 08/29/2002 | WO2002018383A3 Aza heterocyclic derivatives and their therapeutic use |
| 08/29/2002 | WO2002016426A3 Coaster, a human coactivator of steroid receptors |